SD-OCT easier for paediatric cases

Article

SD-OCT is easier to use when obtaining measurements in children, compared to time-domain OCT, claims a recent study in the British Journal of Ophthalmology.

SD-OCT is easier to use when obtaining measurements in children, compared to time-domain OCT, claims a recent study in the British Journal of Ophthalmology..

Dr Mays El-Dairi et al., Department of Ophthalmology, Duke Eye Centre, Durham, North Carolina, USA, retrospectively and prospectively identified 83 eyes of 83 children from the paediatric glaucoma clinic. Peripapillary retinal nerve fibre layer (RNFL) and macular thickness and volume (MV) were compared between four groups. This included normal eyes, eyes with physiologic cupping, mild glaucomatous eye and IOP and severe glaucoma.

SD-OCT findings were compared with TD-OCT values in a subset of subjects who underwent same day scans with both devices. Exclusion were children with neurologic disorders, refractive error >±5 D, pseudophakia and prematurity.

SD-OCT measurements of average RNFL thickness and MV varied among normal eyes, physiologically cupped and severe glaucoma. SD-OCT and TD-OCT measurements made on the same day correlated linearly, but SD-OCT measurements presented with a lower RNFL and higher macular thickness than TD-OCT. In eyes with severe glaucoma, 30% of patients demonstrated unreliable TD-OCT measurements, but reliable SD-OCT measurements.

To read the abstract please click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.